• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结合速率的结构-动力学关系优化——探索动力学图谱

On-rate based optimization of structure-kinetic relationship--surfing the kinetic map.

作者信息

Schoop Andreas, Dey Fabian

机构信息

Proteros biostructures GmbH, Bunsenstrasse 7a, 82152 Martinsried, Germany.

Roche Pharmaceutical Research and Early Development, Small Molecule Research, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland.

出版信息

Drug Discov Today Technol. 2015 Oct;17:9-15. doi: 10.1016/j.ddtec.2015.08.003. Epub 2015 Sep 18.

DOI:10.1016/j.ddtec.2015.08.003
PMID:26724331
Abstract

In the lead discovery process residence time has become an important parameter for the identification and characterization of the most efficacious compounds in vivo. To enable the success of compound optimization by medicinal chemistry toward a desired residence time the understanding of structure-kinetic relationship (SKR) is essential. This article reviews various approaches to monitor SKR and suggests using the on-rate as the key monitoring parameter. The literature is reviewed and examples of compound series with low variability as well as with significant changes in on-rates are highlighted. Furthermore, findings of kinetic on-rate changes are presented and potential underlying rationales are discussed.

摘要

在先导化合物发现过程中,驻留时间已成为体内鉴定和表征最有效化合物的一个重要参数。为了使药物化学能够成功地优化化合物以达到所需的驻留时间,理解结构-动力学关系(SKR)至关重要。本文综述了监测SKR的各种方法,并建议将结合速率作为关键监测参数。对相关文献进行了综述,并重点介绍了结合速率变化小以及结合速率有显著变化的化合物系列实例。此外,还介绍了动力学结合速率变化的研究结果,并讨论了潜在的基本原理。

相似文献

1
On-rate based optimization of structure-kinetic relationship--surfing the kinetic map.基于结合速率的结构-动力学关系优化——探索动力学图谱
Drug Discov Today Technol. 2015 Oct;17:9-15. doi: 10.1016/j.ddtec.2015.08.003. Epub 2015 Sep 18.
2
Impact, determination and prediction of drug-receptor residence times for GPCRs.G蛋白偶联受体(GPCRs)药物-受体驻留时间的影响、测定与预测
Curr Opin Pharmacol. 2016 Oct;30:22-26. doi: 10.1016/j.coph.2016.07.004. Epub 2016 Jul 16.
3
The Role of Target Binding Kinetics in Drug Discovery.靶点结合动力学在药物发现中的作用。
ChemMedChem. 2015 Nov;10(11):1793-6. doi: 10.1002/cmdc.201500310. Epub 2015 Aug 25.
4
Lead optimization via high-throughput molecular docking.通过高通量分子对接进行先导化合物优化。
Curr Opin Drug Discov Devel. 2007 May;10(3):264-74.
5
The use of thermodynamic and kinetic data in drug discovery: decisive insight or increasing the puzzlement?热力学和动力学数据在药物发现中的应用:决定性见解还是增加困惑?
ChemMedChem. 2015 Feb;10(2):229-31. doi: 10.1002/cmdc.201402521. Epub 2014 Dec 23.
6
Alternative variables in drug discovery: promises and challenges.药物研发中的替代变量:前景与挑战
Future Med Chem. 2014 Apr;6(5):577-93. doi: 10.4155/fmc.14.16.
7
Kinetic binding assays for the analysis of protein-ligand interactions.用于分析蛋白质-配体相互作用的动力学结合测定法。
Drug Discov Today Technol. 2015 Oct;17:1-8. doi: 10.1016/j.ddtec.2015.08.004. Epub 2015 Sep 15.
8
The role of binding kinetics in therapeutically useful drug action.结合动力学在具有治疗作用的药物效应中的作用。
Curr Opin Drug Discov Devel. 2009 Jan;12(1):31-9.
9
Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.计算建模方法在药物发现中定量结构-结合动力学关系的应用。
Drug Discov Today. 2018 Jul;23(7):1396-1406. doi: 10.1016/j.drudis.2018.03.010. Epub 2018 Mar 21.
10
The importance of drug-target residence time.药物-靶点驻留时间的重要性。
Curr Opin Drug Discov Devel. 2009 Jul;12(4):488-96.

引用本文的文献

1
Kinetic profiling of novel spirobenzo-oxazinepiperidinone derivatives as equilibrative nucleoside transporter 1 inhibitors.新型螺苯并恶嗪哌啶酮衍生物作为平衡核苷转运蛋白 1 抑制剂的动力学特征分析。
Purinergic Signal. 2024 Apr;20(2):193-205. doi: 10.1007/s11302-023-09948-9. Epub 2023 Jul 10.
2
An integrated modelling approach for targeted degradation: insights on optimization, data requirements and PKPD predictions from semi- or fully-mechanistic models and exact steady state solutions.一种靶向降解的综合建模方法:从半机理或全机理模型和精确稳态解中获得关于优化、数据需求和 PKPD 预测的见解。
J Pharmacokinet Pharmacodyn. 2023 Oct;50(5):327-349. doi: 10.1007/s10928-023-09857-9. Epub 2023 Apr 29.
3
Structure-Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors.
用于开发长滞留时间 LpxC 抑制剂的结构-动力学关系研究。
J Med Chem. 2022 Sep 8;65(17):11854-11875. doi: 10.1021/acs.jmedchem.2c00974. Epub 2022 Aug 29.
4
Quantitative Structure-Activity Relationship (QSAR) Study Predicts Small-Molecule Binding to RNA Structure.定量构效关系 (QSAR) 研究预测小分子与 RNA 结构的结合。
J Med Chem. 2022 May 26;65(10):7262-7277. doi: 10.1021/acs.jmedchem.2c00254. Epub 2022 May 6.
5
Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting 2-Adrenergic Receptor Agonists.长效 2-肾上腺素能受体激动剂的膜介导受体进入和结合机制。
Mol Pharmacol. 2021 Oct;100(4):406-427. doi: 10.1124/molpharm.121.000285. Epub 2021 Aug 1.
6
A structure-kinetic relationship study using matched molecular pair analysis.一项使用匹配分子对分析的结构-动力学关系研究。
RSC Med Chem. 2020 Sep 21;11(11):1285-1294. doi: 10.1039/d0md00178c.
7
Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.观点:配体-受体结合动力学对G蛋白偶联受体治疗靶点的影响
ACS Pharmacol Transl Sci. 2020 Mar 18;3(2):179-189. doi: 10.1021/acsptsci.0c00012. eCollection 2020 Apr 10.
8
In Silico Prediction of the Dissociation Rate Constants of Small Chemical Ligands by 3D-Grid-Based VolSurf Method.基于 3D 网格的 VolSurf 方法预测小分子配体离解速率常数的计算研究。
Int J Mol Sci. 2020 Apr 2;21(7):2456. doi: 10.3390/ijms21072456.
9
A Robust Method for Assaying the Immunoreactive Fraction in Nonequilibrium Systems.一种用于分析非平衡系统中免疫反应性组分的稳健方法。
Pharmaceuticals (Basel). 2019 Dec 3;12(4):177. doi: 10.3390/ph12040177.
10
Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?脂质双层是否调控配体与 G 蛋白偶联受体跨膜正构/变构位点的结合和进入?
Mol Pharmacol. 2019 Nov;96(5):527-541. doi: 10.1124/mol.118.115113. Epub 2019 Apr 8.